Navigation Links
BioElectronics and Pulsed Shortwave Therapy Make Progress
Date:5/23/2013

FREDERICK, Md., May 23, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy:

The FDA's Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was held on May 21, 2013 in Gaithersburg, MD, USA.  The focus of the meeting was very narrow, in that the FDA had instructed the panel to focus solely on the application of non-thermal shortwave diathermy for the treatment of postoperative pain and edema and the treatment of edema following blepharoplasty.  Industry representatives, including BioElectronics President Andy Whelan , presented a compelling case for reclassification.  The recommendation from the FDA's advisory panel was reclassification from Class III to Class II with special controls including a requirement for new clinical data. At this time it is not clear if the requirement for new clinical data applies to existing products.  The FDA will make a final decision on the recommendations of the panel in due course, though BioElectronics believes that the FDA will follow the panel's recommendations.

"Overall, we see the advisory panel and the FDA's recommendations as a positive and potentially significant development," stated Ian Rawe , BioElectronics Director of Clinical Research.  "After decades of use and research, the FDA now believes that the available evidence suggests that shortwave devices can be safely regulated. If existing cleared devices are compelled to submit new clinical data, our 3rd Molar Extraction clinical study at Tufts Dental School, Boston, meets all the FDA's clinical research standards. This study is evaluating both postoperative pain and edema, with edema being quantified with a 3D digital imaging system (http://www.3dmd.com/). Therefore, because of these expected developments and with expanded clinical research in place we are confident of moving forward."

We also continue to press our Petitions in the FDA's Commissioner's Office of Science Integrity for our musculoskeletal and menstrual pain market clearances and we are optimistic that this reclassification concession will help expedite market clearances. 

About BioElectronics Corporation

BioElectronics (www.bielcorp.com) is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care.

Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com

 

 

 


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Presents FDA Reclassification Panel
2. BioElectronics New Patent Published
3. BioElectronics to Ease pain in Iraq
4. BioElectronics Selects New South Korean Distributor for its Healing and Pain Products
5. BioElectronics Obtains Additional US Patent For Its Unique Pain Devices
6. BioElectronics Enters Malaysias Pain Relief Market
7. BioElectronics Unique Pain Relief Product Featured on Leading Healthcare Show in Spain
8. BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
9. BioElectronics CEO Honored by Chabad at Johns Hopkins Medicine
10. BioElectronics Expands European Distribution to Malta
11. BioElectronics Announces Publication of Patent Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... RALEIGH, N.C. (PRWEB) , ... June 19, 2020 ... ... Evalueserve Global Recovery Index (EGRI) , a comprehensive recovery index that combines ... and social interactions. The index seeks to provide a holistic way of looking ...
(Date:6/19/2020)... ... ... The Conference Forum is pleased to announce the launch of the PODD newsletter. ... Drug Delivery conference, which features a wide range of drug delivery technologies and fosters ... impact and advancing the field of drug delivery. It will cover a wide range ...
(Date:6/19/2020)... LOS ANGELES (PRWEB) , ... June 18, 2020 , ... ... Angeles-based hospital’s recent efforts to encourage those in the community to prioritize their health ... set to make doctor visits safer. The article reports that many hospitals in Southern ...
Breaking Medicine Technology:
(Date:6/24/2020)... BEACH, Calif. (PRWEB) , ... June 24, 2020 , ... ... it has launched a new website at http://www.evolvednaturals.com The newly launched website ... of broad-spectrum CBD oils , and a comprehensive line of skincare & ...
(Date:6/24/2020)... , ... June 24, 2020 , ... The world’s largest ... comparison survey that details which cell phones will be worth the most two years ... on the market - iPhone, Samsung, Google, Sony and LG - and compared their ...
(Date:6/23/2020)... ... June 23, 2020 , ... Anesthesia Progress —Receiving dental ... alike. The virus, which is primarily found in oral, nasal, and pharyngeal mucosa ... contact contamination, or by aerosols produced during aerosol-generating procedures (AGPs). Given the transmission ...
(Date:6/23/2020)... ... June 22, 2020 , ... Communities from ... projects in 11 categories this year: 55+, Active Adult, Affordable, Assisted Living, ... Care and Standalone Memory Care. , “Particularly in light of reduced ...
(Date:6/23/2020)... ... June 22, 2020 , ... Cryoshift, the Valley’s newest ... Located at 3755 South Gilbert Road at the Crossroads Towne Center, Cryoshift offers a ... “The first time I tried cryotherapy, it was a little uncomfortable, but as soon ...
Breaking Medicine News(10 mins):